OPS 5-820 Patients who undergo a hip total replacement (THR) due to hip osteoarthritis (ICD-10: M16) M16
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: For the study, patients will be included who are indicated for a hip joint endoprotheses surgery due to hip osteoarthritis. Patients voluntarily participate in the study and must meet the criteria for surgical indication according to the AWMF S3 guideline (DGOU, 2021, EKIT-Hüfte).
Exclusion criteria
Exclusion criteria: Patients who have cancer or malignant tumors, as well as those suffering from other incurable or severe illnesses requiring specific causal medical or drug treatment, will be excluded from the study. Additionally, patients with significant cognitive impairment or dementia, severe psychiatric disorders (e.g., schizophrenia), or those with identified drug abuse, including regular opioid consumption, will be excluded (exceptions include ICD-10 diagnosis F45.41: Chronic pain disorder with somatic and psychological factors, or pain-related depressive or anxiety disorders, mild to moderate, such as ICD-10 diagnoses F32.0, F32.1, or temporary opioid use to bridge the time until the surgery).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity NRS (0-10) Comparison between timepoints T1 (4 days preoperatively) and T3 (4 days postoperatively, discharge from hospital) | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional capacity (HHS; Harris, 1969), postoperative recovery (QoR, 11 Items; Kahl et al., 2021), mood (STADI, 40 Items; Laux et al., 2013), sensitivities (SBI; Klinger et al, 1999), self-efficacy (ASES-D, 9 Items; Müller et al, 2003), treatment expectation (GEEE; Rief et al., 2021; SETS; Younger et al., 2012; PR-OP Behandlungserfolg; Stuhlreyer et al., 2022), perceived warmth and competence of the study physician (SCM, 12 Items; Fiske et al., 2007), pain medication intake (pain diary) | — |
Countries
Germany
Contacts
Universitätsklinikum Hamburg-Eppendorf